This Solicitation opportunity from Department Of Defense was posted on September 2, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

GABAPENTIN CAPSULES

Closed

SPE2DP-26-T-4867Federal

Submission Closed09/08/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

Federal

Sodium Bicarbonate Injection ManufacturingThis subcontract involves the manufacturing of Sodium Bicarbonate 84mg/mL Injection in 50mL vials to support prime contractors on Department of Veterans Affairs pharmaceutical procurement projects. The scope of work encompasses the entire production process, including chemical synthesis, formulation, and the sterile filling and sealing of vials. All operations must be performed within the United States using automated vial filling lines and sterile cleanroom facilities. To ensure product safety and regulatory adherence, the manufacturer is required to maintain a unique NDC number and strictly follow FDA CGMP compliance. The final deliverable consists of finished, sterile Sodium Bicarbonate vials. This project is managed under Nac Pharmaceuticals for the Department of Veterans Affairs, falling under NAICS code 325412.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

6505--Sodium Bicarbonate Injection Vial Restricted to Made in America

Solicitation # 36E79726R0041

The Department of Veterans Affairs intends to award a firm-fixed requirements-type contract for Sodium Bicarbonate 84mg/mL Injection 50mL vials, with an estimated annual usage of 65,587 bottles. This procurement is restricted to suppliers with products manufactured in the United States in accordance with FAR 6.103-3 and will be issued in a commercial item format per FAR Part 12. The contract will support multiple agencies, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers, with distribution managed through the VA and DOD Pharmaceutical Prime Vendor Programs. The award will be granted to a single responsible offeror capable of providing an uninterrupted source of supply for a base period of one year, with four pre-priced one-year option periods. Under NAICS code 325412, the solicitation requires offerors to provide a unique NDC number and the exact drug name as it appears on the label. Strict labeling standards apply: the contractor's unique NDC label must be the only label on the product, and labels cannot be affixed over existing ones; however, they must allow VA labels to adhere securely on top. While glass bottles are acceptable, all packaging must be compatible with automated dispensing units such as Opti-fill and Baxter ATC Canisters. The solicitation is expected to be issued on October 21, 2026, with a tentative closing date of November 18, 2026, and all communications and submissions must be handled electronically via SAM.gov.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

6505--Imatinib Tablets

Solicitation # 36E79726R0036

The Department of Veterans Affairs is seeking an unrestricted procurement to establish a firm fixed price, indefinite-delivery requirements contract for Imatinib Mesylate Tablets in 100MG and 400MG strengths. This contract supports a wide range of federal entities, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The award consists of a base year plus four pre-priced one-year option periods, with estimated annual quantities of 6,397 bottles for the 100MG tablets and 19,504 bottles for the 400MG tablets. Award will be based on the lowest evaluated price for proposals that meet all non-cost acceptability standards, including a review of past performance to determine contractor responsibility. Strict technical and regulatory requirements apply to this procurement. All products must be compatible with automated dispensing units and packaged in non-glass cylindrical bottles with specific dimensions and safety caps. Labeling must include a unique 11-digit NDC number and conform to GS1-128 or HIBCC HIBC bar-coding standards, as well as Drug Supply Chain Security Act (DSCSA) requirements for two-dimensional data matrix bar codes and serialized transaction information. Offerors must maintain an acceptable cGMP status with the FDA and provide an ANDA, NDA, or BLA. Proposals are due by October 30, 2026, and must be submitted in Word or PDF format via email.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

Hydrogen Peroxide Topical Solution (USP) SupplierThis subcontract involves the supply of 3% stabilized Hydrogen Peroxide Topical Solution, USP, to prime contractors supporting Department of Defense projects under the Medical Supply Chain Pharm FSA. The supplier is responsible for manufacturing or sourcing over-the-counter stabilized solutions in 473ml bottles that strictly adhere to FDA regulations and United States Pharmacopeia standards. Key compliance requirements include the provision of current Material Safety Data Sheets and strict adherence to 49 CFR and 29 CFR regulations regarding the handling and transport of hazardous materials. The performance of this contract is centered in FPO 96671, with a response deadline set for October 21, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Hand Held Assay Unit SupplierThis subcontract involves the manufacture or sourcing of 63,000 boxes of Hand Held Assay units, identified by NSN 6665-01-504-8535, to support prime contractors for the DLA Weapons Support Maritime Supply Chain. These units are designated as Critical Application Items and must be delivered to DLA Distribution in Norfolk, Virginia. A key requirement is the maintenance of a non-extendable shelf life of 24 months, with at least 85 percent of that shelf life remaining at the time of delivery. To be eligible, the supplier must adhere to strict security and regulatory standards, including a CMMC Level 2 self-assessment and full compliance with DFARS 252.204-7012. The opportunity was posted on October 15, 2026, with a response deadline of November 2, 2026, falling under NAICS code 325412 for the Department of Defense.

DLA WEAPONS SUPPORT MARITIME SUPPLY CHAIN

POSTED

DEADLINE

Supply of Waterless Hand Sanitizer (NSN 8520-01-346-9200)This subcontract involves the supply of unscented, waterless hand cleanser for prime contractors supporting Department of Defense projects under the DLA Troop Support Medical Supply Chain. The required product is a 70 percent ethyl alcohol base cleanser provided in 4 fluid ounce bottles, specifically meeting NSN 8520-01-346-9200 specifications. All supplies must be delivered in packaged units of 24 bottles and maintain a minimum shelf life of 36 months. The contract mandates strict adherence to Medical Marking Standard No. 1, MIL-STD-129, and MIL-STD-2073-1E, while ensuring full compliance with the Buy American Act and the Berry Amendment. Performance for this requirement is centered at Fort Riley, Kansas. Interested parties must respond by October 21, 2026, under NAICS code 325412.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Adhesive Rubber Tape (NSN 9320-01-182-9220)This subcontract, issued by Construction and Equipment MRO SVC I for the Department of Defense, involves the supply of adhesive rubber tape under NSN 9320-01-182-9220. The requirement is for 259 boxes of pink rubber tape, specifically measuring 360 inches in length, 0.5 inches in width, and 0.125 inches in thickness, meeting part numbers 91511643 PNK or SM9151 from ITW Polymers Sealant. The material must have a minimum shelf life of 12 months and be delivered to DDSP New Cumberland. The contract is a total small business set-aside under NAICS code 325412. Strict adherence to the Buy American Act and the Berry Amendment is required. Packaging and palletization must comply with MIL-STD-2073-1E, MIL-STD-129, and RP001 standards, with each box containing 32 rolls.

CONSTRUCTION & EQUIPMENT MRO SVC I

POSTED

DEADLINE

Berry Flavored Electrolyte Oral Rehydration Powder SupplyThis subcontract involves the supply of berry-flavored electrolyte oral rehydration powder for prime contractors supporting Department of Defense Medical Supply Chain projects. The manufacturer must produce 21g packets containing specific concentrations of sodium, potassium, citrate, magnesium, and zinc using pharmaceutical-grade mixing equipment. Each delivery consists of two packages containing 100 packets each, with a required shelf life of 36 months. Strict adherence to regulatory standards is mandatory, including compliance with the Berry Amendment, the Buy American Act, and FDA/OTC standards. The contract is managed under NAICS code 325412 for the Medical Supply Chain Pharm FSA, with the place of performance designated as FPO 09591-2600.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Permethrin Cream Rinse ManufacturerThis subcontract through the Department of Defense Medical Supply Chain Pharm FSA requires a manufacturer to produce finished 1% w/v Permethrin active ingredient cream rinse for prime contractors. The scope of work includes the formulation and manufacturing of the cream, which must be packaged in 2 fl oz plastic squeeze bottles equipped with application combs. To meet quality standards, the provider must utilize pharmaceutical-grade mixing and filling equipment to ensure a 24-month shelf life and full FDA compliance. The selected manufacturer is responsible for delivering an FDA-registered product that includes all necessary Safety Data Sheets and Hazardous Communication Standard labels. Performance for this contract is centered in Watervliet, New York, under NAICS code 325412. Interested parties must adhere to the response deadline of October 21, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of MIL-SPEC Electrical Insulation TapeThis subcontract involves the supply of 100 rolls of opaque electrical insulation tape for prime contractors supporting the DLA Weapons Support ASC. The tape must be 1.5 inches wide, 0.010 inches thick, and 108 feet in length, conforming strictly to MIL-I-19166C specifications. To ensure quality and longevity, the product must utilize silicone adhesive to maintain a 12-month shelf life. The supplier is required to provide Source Approval Request documentation and maintain a QPL/QML listing. All items must be packaged according to MIL-STD-2073-1E and MIL-STD-129 standards. Delivery of the 100 rolls is designated as FOB Origin. The response deadline for this opportunity is October 23, 2026.

DLA WEAPONS SUPPORT ASC SUPPLIER OPER AE AND AF DIV

POSTED

DEADLINE

Supplier of Lemon Flavored Electrolyte Oral Rehydration PowderThis subcontract involves the supply of lemon-flavored electrolyte oral rehydration powder to prime contractors supporting Department of Defense projects under the DLA Troop Support Medical Supply Chain. The required product consists of over-the-counter oral rehydration powder distributed in 21g pre-measured packets, formulated with specific concentrations of sodium, potassium, citrate, magnesium, and zinc. Each delivery must include two packages containing 100 packets each, identified by NSN 6505016462692. To ensure quality and safety, all supplies must adhere to OTC pharmaceutical standards, Medical Marking Standard No. 1, and ASTM D3951 packaging requirements. The contract falls under NAICS code 325412 and is managed by the Medical Supply Chain Pharm FSA. Performance for this contract is designated for FPO 09591-2600.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0117

Solicitation SPE2DP-27-T-0117, issued by DLA Troop Support, is for the procurement of Permethrin Cream Rinse (NSN 6505-01-256-4972). The required product is a 1% w/v Permethrin active ingredient cream rinse provided in a 2 fl oz plastic squeeze bottle and must include a comb. The total quantity requested across three line items is 9 units, with delivery required within 20 days after the order is placed. Delivery is FOB Destination to locations in New York and Kentucky. The product has a total shelf life of 24 months, and it must have at least 21 months of remaining shelf life upon receipt by the first government activity. The contractor must adhere to strict medical and hazardous materials standards, including marking in accordance with Medical Marking Standard No. 1 and packaging per MIL-STD-2073-1E. Because the item is regulated by the FDA and classified as hazardous material, suppliers must submit Safety Data Sheets (SDS) and Hazardous Communication Standard labels prior to award. Invoicing and receiving reports must be processed through the Wide Area WorkFlow (WAWF) system. This acquisition is assigned NAICS code 325412 and incorporates various FAR and DFARS clauses, including the Buy American Act and specific cybersecurity requirements for safeguarding covered defense information. Quotations are due by October 21, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

3 days ago

DEADLINE

in 3 days

AI Contract Overview

Contract SPE2DP-26-T-4867 is a solicitation issued by the Department of Defense Medical Supply Chain Pharmacy for the procurement of Gabapentin Capsules, 100 mg, in quantities of 5 bottles of 100 capsules each. The item is identified by NSN 6505-01-387-1892 and is regulated by the FDA. It requires a non-extendable shelf life of 36 months and must be stored at 25 degrees Celsius, with permitted excursions between 15 and 30 degrees Celsius. The contract specifies that packaging and marking must adhere to Medical Marking Standard No. 1 and DLA packaging requirements, with specific instructions for both hazardous and non-hazardous materials. Delivery is set for the USS Makin Island LHD 8 via fastest traceable means, with an original required delivery date of April 3, 2026, and a delivery window of 5 days after receipt of order. The procurement falls under NAICS code 325412 and requires destination inspection and acceptance. Potential manufacturers listed include Marlex Pharmaceuticals Inc, Scigen Pharmaceuticals Inc, and Cipla USA Inc.

General Info

DoD procurement of Gabapentin 100mg capsules for delivery to USS Makin Island.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

UNIT 100222 BOX 1, FPO, AP, 96672, USA

Set-Aside

NONE

Documents

SPE2DP-26-T-4867 RFQ

19 pages · rfq

High

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedSep 2

Solicitation

Response DeadlineSep 8

Deadline has passed

Submission Closed

09/08/2026, 05:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Contacts1 person available

OfficeUSA

Organization / AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Office AddressUSA

Contacts

JAMES MCCULLOUGH

contact@example.gov

+1 (555) 000-0000

Full Description

GABAPENTIN CAPSULES
GABAPENTIN CAPSULES, 100 MG, 100S
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
U/I "BT" (100'S)
Store at 25C (77F); excursions permitted between 15C to 30C (59F to 86F) see USP Controlled Room Temperature. This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
SPE2DP-26-T-4867
SECTION B
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
MARLEX PHARMACEUTICALS INC 1TAP7 P/N NDC10135-0644-01 SCIEGEN PHARMACEUTICALS INC 8NLP1 P/N NDC50228-0179-01 CIPLA USA INC 7WV84 P/N NDC69097-0813-07
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016153280 0001 BT 5.000
NSN/MATERIAL:6505013871892
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
R23171
USS MAKIN ISLAND LHD 8
UNIT 100222 BOX 1
FPO AP 96672
US
VESSEL SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
SPE2DP-26-T-4867
SECTION B
PR: 7016153280 PRLI: 0001 CONT’D
FREIGHT SHIPPING ADDRESS:
R23171
USS MAKIN ISLAND LHD 8
DLA VENDORS: USE VSM FOR
US
RDD 777 SHIPMENT. SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
M/F: (TCN) R231716089MH06
RDD: 777
PROJ: EP5 TP 1
SUPP ADD: YNMH01 SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 03
DIC: A4A DIST: 9B ADV: 2A FC: N7
Need Ship Date:00/00/0000 Original Required Delivery Date:04/03/2026
SPE2DP-26-T-4867 NSN/Part Number: 6505-01-387-1892 Quantity: 5 BT Purchase Request: 7016153280QTY: 5 Delivery: 5 days ADO